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It was reported that 30-50% of inpatients are in a malnutri-
tion status. Measuring the prealbumin level is a sensitive and
cost-effective method for assessing the severity of illness in
critically or chronically ill patients. However it is uncertain
whether or not the prealbumin level correlates with the level
of nutrition support and outcomes in critically ill patients. The
aim of this study was to evaluate serum prealbumin level as
an indicator of the effectiveness of nutrition support and the
prognosis in critically ill patients. Forty-four patients who
received total parenteral nutrition for more than 7 days at an
intensive care unit (ICU) were studied. The serum prealbumin
was measured at the initial time of nutrition support and at
the almost seventh day since the first measurement. The patients
were allocated into two groups. In Group 1 (n=31) and 2 (n=
13), the prealbumin level increased and decreased, respec-
tively. Age, APACHE II score, nutrition status, nutritional
requirement and amount of supply, mortality, hospital day and
ICU day in the two groups were compared. The serum
prealbumin level increased in 31 out of the 44 patients. The
average calorie intake was 1334 Kcal/day (83% of energy
requirement) in Group 1 and 1170 kcal/day (76% of energy
requirement) in Group 2 (p=0.131). The mortality was 42%
in Group 1 and 54% in Group 2 (p=0.673). The average
hospital day/ ICU day in Groups 1 and 2 were 80 days/38 days
and 60 days/31 days respectively. In conclusion, in critically
ill patients, the serum prealbumin level did not respond sensi-
tively to nutritional support. In addition an increase in the pre-
albumin level dose not indicate a better prognosis for critically
ill patients.
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INTRODUCTION
It was reported that 40% of patients are under-
nourished and 34% are overweight.1 Malnutrition
remains a largely unrecognized problem in hospi-
tals and highlights the need for education on
clinical nutrition.1 The importance of a clinical and
empirical assessment of the protein energy malnu-
trition (PEM) is without question. Only recently,
the relationship between the nutrition status and
the hospital course and the risk of complications
and/or death, has been studied, even though
most clinicians subjectively feel that malnutrition
increases the risk to surgical patients.
The serum proteins with shorter half-lives than
albumin have been examined as potential indica-
tors of malnutrition. Several studies have sug-
gested that there are strong correlations between
malnutrition and the serum protein such as albu-
min, transferrin and prealbumin.2-4 Readily avail-
able laboratory tests that are indicators of a
current and changing nutrition status include the
urinary nitrogen excretion and prealbumin. More
recently, prealbumin has become the most fre-
quently assayed protein in assessing PEM staus.5,6
Because prealbumin has a relatively short plasma
half-life of 2.5 days, it is expected that instant
changes in response to PEM and therapy can
occur. However, there is little data correlating the
prealbumin level with the patient's outcome in
literatures.
The aim of this study was to evaluate the serum
prealbumin level as a sensitive indicator of the
effectiveness of nutrition support and as a prog-
nostic indicator in critically ill patients.
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MATERIALS AND METHODS
This study enrolled the patients with their total
parenteral nutrition (TPN) supplied for more than
7 days selected from the general intensive care
unit (ICU) patients under the nutrition support
team (NST) care for 9 months from November
2002 through June 2003.
In our hospital, the NST is a multidisciplinary
team that includes doctors, nurses, pharmacists
and dietitians. The indication for parenteral nutri-
tion (PN) is a nonfunctioning gastrointestinal tract
in a patient who requires nutrition support, such
as peritonitis, intestinal obstruction, intestinal
hemorrhage, intractable vomiting, paralytic ileus,
severe pancreatitis, stool output 1 L/day, high-
output entero-cutaneous fistula, ( 500 ml/day or
tendency to increase) and short bowel syndrome.
In addition the anticipated duration of PN is at
least 7 days.
There were patients whose prealbumin level
had been measured more than twice. The serum
prealbumin, albumin and total lymphocyte count
(TLC) were measured at the first day of nutrition
support by NST and at the 7th day of nutrition
support care. The patients were classified into two
groups according to the change in the prealbumin
level. Group 1 (N=31) comprised of patients
whose prealbumin level increased and Group 2
(n=13) included those whose prealbumin level
decreased. The two groups were compared ac-
cording to the criteria such as the nutrition status,
the nutrition requirement and supply amount,
biochemical data, hospital days, ICU days and
mortality. The nutrition status of the patients was
assessed according to the ICD-9-CM malnutrition
code definition.7
Data was collected from the NST follow-up
sheet produced by the team for monitoring the
patients receiving NST care as well as by the
medical records for mortality, hospital days and
ICU days. The difference in the parameters
between the groups was analyzed by a t-test. A
two-tailed p value 0.05 was considered signifi-
cant. The calculations were performed using
SPSS for windows 9.01 (SPSS Inc. Chicago IL.)
RESULTS
There was no significant difference in the basic
characteristics of the two groups, such as age,
height, weight, body mass index (BMI) and
APACHE II score (Table 1). There were also no
significant differences in the main diagnosis and
nutrition status between the two groups (Table 2,
3). The most common diseases in both groups
were infection and gastrointestinal failure. Thirty-
four out of 44 patients had an adequate to mild
nutrition insufficiency status. There was no signi-
ficant difference in the protein and energy supply
between the two groups.
Previously, when the patients were admitted to
the ICU, the physicians supplied nutrition to their
patients without consulting the NST. On average,
the quantity of calories and proteins in both
Table 1. Patient's Characteristics
Characteristics Group 1 (n=31) Group 2 (n=13) p
Age (yrs) 66.3 ± 15.7 64.3 ± 17.3 0.710
Sex (M/F) 19/12 8/5 1.000
Height (cm) 165 ± 0.1 162 ± 0.1 0.293
Weight (kg) 59.6 ± 8.7 58.8 ± 9.2 0.384
IBW (kg) 59.6 57.4 0.375
BMI (kg/m2) 21.7 ± 3.2 21.5 ± 3.1 0.846
APACHE score 18 ± 6.3 16.2 ± 6.4 0.369
Values are mean ± SD.
IBW, ideal body weight; BMI, body mass index.
Group 1 comprised those whose prealbumin level increased and Group 2 comprised those whose level decreased.
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groups supplied only 55% (Group1) and 52%
(Group 2) of the patients' requirement. After NST
care for one week, the patients were provided
more than 80% of their nutritional demand. It
took an average 5 days for the physician to
consult the NST after the patients had been
admitted to the ICU (Table 4).
In Group 1, the biochemical parameters such as
albumin, TLC were significantly higher. In Group
2, the TLC was significantly lower (p < 0.05)
(Table 5). However, there were no statistical dif-
ferences between the groups in terms of mortality
Table 2. Distribution of the Main Diagnosis Categories
Group 1 (n=31) Group 2 (n=13)
Infection 9 4
GI failure 5 3
Respiratory failure 4 0
Cardiovascular 5 2
Trauma 3 1
CNS disorder 1 1
Others 4 2
Table 3. Nutrition Status
Nutrition status Group 1 (n=31) Group 2 (n=13)
Adequate states 3 0
Mild malnutrition 21 10
Moderate malnutrition 5 1
Severe malnutrition 2 2
The nutrition status of the patients was assessed according to ICD-9-CM malnutrition code definition.
7
There was no significant
difference in the distribution of the nutrition status between the groups (p=0.846)
Table 4. Energy and Protein Supply for the Two Groups
Group 1 (n=31) Group 2 (n=13)
Energy intake (kcal)
P
N
866 ± 422
1334 ± 346
864 ± 352
1170 ± 254
0.993
0.131
% of energy intake
P
N
54 ± 27
83 ± 22
57 ± 25
76 ± 15
0.703
0.300
Protein intake (g)
P
N
52 ± 17
76 ± 15
49 ± 12
73 ± 15
0.464
0.518
% of protein intake
P
N
49 ± 30
70 ± 25
58 ± 28
68 ± 17
0.377
0.784
Values are represented as a mean ± SD.
% of the energy intake, energy intake/energy requirement × 100; % of protein intake, protein intake/protein requirement × 100; P,
nutrition supply was carried out by a physician before consulting the nutrition support team; N, nutrition supply was carried out
by the nutrition support team after consultation by a physician.
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as a prognostic indicator (p=0.673). In addition,
hospital day and ICU day as another prognostic
indicators were similar in the two groups (Table
6).
DISCUSSION
Malnutrition is an alteration in the body com-
position in which deficiencies in the level of
macronutrients results in a reduced body cell
mass, organ dysfunctions, and an abnormal serum
chemistry value. Nutrition support plays a vital
role in the prevention and treatment of nutritional
deficiencies in appropriately selected, at risk,
critically ill patients.8,9
The use of the serum protein levels for nutri-
tional assessment is well established. The rela-
tionship of serum albumin concentration 3.5 g/
dl to an increased morbidity and mortality in
medical and surgical patients is well documented.
10,11 However, it has also been suggested that a
biochemical assessment is a less reliable marker of
the nutrition status. The albumin concentrations
slowly respond to protein restriction and are more
a reflection of the patient's illness than the nutri-
tional intake. Prealbumin is more sensitive, with
a short half-life, but it might be elevated during
chronic inflammation and be reduced with a
current ion deficiency. It is known that prealbu-
min responds to the nutritional intake but is also
affected by the disease process.1
Prealbumin responds quickly to the onset of
malnutrition and rises rapidly with the adequate
protein intake. In the patients who receive optimal
nutrition support, the prealbumin level may in-
crease 4 mg/dl per week.
12
Several studies have reported that patients with
low prealbumin levels have a shorter length of
stay in hospital stay and fewer complications,
lower morbidity and possibility mortality, if they
are given either intravenous or oral hyperalimen-
tation.5,13,14 However, this study could not find
any significant difference in the amount of nutri-
tion support and the prognosis of these patients
with an increased serum prealbumin level com-
Table 5. Biochemical Data for the Two Groups
Group 1 (n=31) Group 2 (n=13)
1st Prealbumin (mg/l) 106 ± 69 124 ± 79
2nd Prealbumin (mg/l) 157 ± 84* 90 ± 45*
1st albumin (g/dl) 2.7 ± 0.4 2.9 ± 0.4
2nd albumin (g/dl) 2.9 ± 0.4* 2.6 ± 0.4
1st TLC (/mm3) 958 ± 514 1021 ± 703
2nd TLC (/mm3) 1091 ± 571* 998 ± 549*
Values are represented as a mean ± SD.
1st, measurement at the initiation of nutrition support by NST; 2nd, measurement at 7 days after initiation of nutrition support by
NST; TLC, total lymphocyte count.
*significant difference from 1st measurement (p<0.05), significant difference from group 1 (p<0.05).
Table 6. Hospital day, ICU day and mortality
Group 1 (n=31) Group 2 (n=13) p
Mortality 14 (42%) 7 (54%) 0.673
Hospital day 88 ± 79 60 ± 37 0.400
ICU day 39 ± 37 31 ± 11 0.393
Values are mean ± SD.
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pared to the patients with a decreased serum pre-
albumin level. This means that a change in the
serum prealbumin level did not sensitively re-
spond to nutrition support and was good prog-
nostic indicator in critical ill patients.
The reason for why the prealbumin does not
respond sensitively to nutrition support may be
explained as follows. Sometimes, a change in pre-
albumin does not reflect the nutrition intervention
of the patients. At the same time, an evaluation
in prealbumin levels in many, if not most, cases
may represent many other factors that may result
in reducing levels. Indeed, malnutrition per se is
a fairly uncommon cause of a reduced prealbumin
level, particularly in developed countries. Pro-
babley the most common cause of the low level
is the acute phase response, whether it is due to
acute or chronic inflammation or tissue necrosis as
observed in trauma and malignancy patients. In-
flammatory cytokines reduce the level of prealbu-
min synthesis by the liver. Hemodilution and ex-
travascular space expansion due to inflammation
or other causes also play a prominent role.15 As
a consequence of these facts, prealbumin should
not be used to monitor the adequacy of nutrition
during the acute stress phase. However it dose not
mean that the information provided by the preal-
bumin level is not valuable.
There are several reasons why nutrition support
did not contribute to the patient's outcome.
First, as shown in Table 3, the nutrition status
of most enrolled patients was not bad.
Patients obtaining the desired effect from nutri-
tional support are most likely those with baseline
malnutrition or in those with a protracted period
of starvation. In well-nourished persons with a
short period (< 1 week) of nil per os status, it is
very difficult to demonstrate an improvement in
outcome with nutrition support. Second, patients
who received TPN had a higher mortality rate
than was expected in this study. The mortality
rate of this institution at APACHE score 16 to 18
was 10% in another study. In this study, the
patients had similar APACHE II scores on ICU
admission but their mortality rate was approxi-
mately 45%.
One of the possible explanations is that the
APACHE II score system does not encompass the
bowel function. The fact that patients who re-
ceived TPN had bowel failure might have been
underestimated. However, it would be difficult to
reflect the effect of nutrition support in critically
ill patient with a mortality approaching 45%.
Third, it was reported that if adequate nutrition
support were delayed, the patients' outcomes
would deteriorated. The data, comparing those
who started adequate nutrition support in less
than 5 days with those who started after 5 days
showed that the mortality and complication were
markedly increased in the delayed nutrition sup-
port group.16 In our cases, adequate nutrition
support was begun at the 5th ICU day. It probably
decreased the effectiveness of the nutrition sup-
port in critical ill patients. Fourth, the prealbumin
level as an indicator of nutritional intervention
would be measured serially. Mittman et al. re-
ported that for each 1 mg/dl increase in the serum
prealbumin level at enrollment, there was a 9%
decrease in the relative risk of death in hemodi-
alysis patients.17 This study investigated the rela-
tionship between the patient's outcome and the
initial change in the prealbumin level at the entry
period of nutrition support. If the following nutri-
tion intake did not meet the change in the
patient's requirement, the mortality might have
become higher. In addition, approximately half of
the patients were in Group 1, whose second preal-
bumin level was still under the normal range (
160 mg/L). However, they did show an increasing
trend in the prealbumin level, but they probably
did not reach the normal range. Therefore, it is
difficult to regard our comparison on the outcome
of the two groups as a comparative result reflect-
ing the effect of nutrition support.
It was reported that the inclusion of prealbumin
in an admission screening panel identified 44% of
patients at nutritional risk, who would have been
missed if evaluated by the serum albumin level
alone.
18
Some authors have recommended moni-
toring the prealbumin and C-reactive protein
(CRP) levels to monitor the acuity of the inflam-
matory response. When the CRP level is at its
height, the prealbumin level is likely to be at its
nadir. The fall in the CRP level should start if the
nutrition support is adequate.19
This study found that at the initial period of the
intensive care unit, the serum prealbumin level
did not respond to nutrition support sensitively
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the increase in the prealbumin level did not
indicate a better prognosis in critically ill patients.
More study on the relationship between the long-
term results and the serial change in the preal-
bumin level with the patient's outcome.
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